Gonzaga, Ellamae A.

HRN: 04-04-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2025
METRONIDAZOLE 500MG (TAB)
08/20/2025
08/26/2025
PO
500 Mg
TID
Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines